ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality ...
ImmuCell Corporation, headquartered in Portland, Maine, is a publicly traded animal-health biologics company (Nasdaq: ICCC) founded in 1982. The company specializes in the development, manufacturing, and commercialization of products that enhance the vitality and output of dairy and beef cattle, serving both U.S. domestic and international markets. ImmuCell's core business revolves around hyperimmunization technology, which improves colostrum quality—nature's most powerful defense for newborn calves. Its flagship product, First Defense, is an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also offers Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus, and Dual-Force First Defense, which incorporates a whey protein concentrate for nutritional and animal feed supplement applications. Additionally, ImmuCell provides the California Mastitis Test, a diagnostic tool used to quantify somatic cell counts in milk and identify affected udder quarters. Currently under development is Re-Tain, a Nisin-based intramammary therapy targeting subclinical mastitis in lactating dairy cows. Financially, ImmuCell has a market cap of approximately $99 million, with a price-to-sales ratio of 3.3 and a negative net profit margin of -1.8% in the trailing twelve months, reflecting ongoing investments in R&D and product development. The company employs 73 full-time employees, with a focus on scientific research and sales/marketing. Key leadership includes President and CEO Olivier te Boekhorst, who brings over 25 years of experience, and Chief Financial Officer Timothy C. Fiori. ImmuCell distributes its products primarily through a network of animal health distributors, both domestically and internationally, including partnerships in South Korea and Japan. The company is dedicated to creating scientifically proven, practical products that improve animal health and productivity, aiming to deliver long-term value to shareholders through innovation and market expansion.
